AtriCure (ATRC) Misses Q4 EPS by 13c, provides guidance
Tweet
Share
E-mailGet Alerts ATRC Hot Sheet
Price: $59.12 +3.47%
Revenue Growth %: +12.6%
Financial Fact:
Interest expense: -530K
Today's EPS Names:
ALZN, ASPU, USAU, More
Revenue Growth %: +12.6%
Financial Fact:
Interest expense: -530K
Today's EPS Names:
ALZN, ASPU, USAU, More
Join SI Premium – FREE
AtriCure (NASDAQ: ATRC) reported Q4 EPS of ($0.33), $0.13 worse than the analyst estimate of ($0.20). Revenue for the quarter came in at $124.28 million versus the consensus estimate of $120.37 million.
GUIDANCE:
AtriCure sees FY2025 EPS of ($0.64)-($0.57), versus the consensus of ($0.60). AtriCure sees FY2025 revenue of $517-527 million, versus the consensus of $522.6 million.
For earnings history and earnings-related data on AtriCure (ATRC) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Nucor projects Q3 2026 earnings above prior year, below estimates
- AtriCure Inc. (ATRC) PT Raised to $65 by Stifel - Physicians Favor LAAM Technology
- Barclays Reinstates Smiths Group (SMIN:LN) (SMGKF) at Equalweight
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
